Multi-Functionality in Theranostic Nanoparticles: is more Always Better?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Zn(II) porphyrin-encapsulated MIL-101 for photodynamic therapy of breast cancer cells.Lasers in medical science · 2023
   Article
2. Development of nano- and microdevices for the next generation of biotechnology, wearables and miniaturized instrumentation.RSC advances · 2022
   Review
3. Progress in Clinical Trials of Photodynamic Therapy for Solid Tumors and the Role of Nanomedicine.Cancers · 2020
   Review
4. New photosensitizers for photodynamic therapy.The Biochemical journal · 2016
   Review
5. Physical energy for drug delivery; poration, concentration and activation.Advanced drug delivery reviews · 2014
   Review
6. Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection.Expert review of anti-infective therapy · 2013
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

5 authors.

Funding

Abstract

PubMed holds no abstract for this paper.